Horizon, Pozen jump after Vimovo deal

|About: Horizon Pharma plc (HZNP)|By:, SA News Editor

Moving sharply higher in early trading are shares of Horizon Pharma (HZNP +28.6%) and Pozen (POZN +13.6%) .

Investors are clearly upbeat on HZNP's move to acquire the U.S. rights to Vimovo.

For more on the deal see here.